Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria

被引:36
作者
Schmitt, SK
Knapp, C
Hall, GS
Longworth, DL
McMahon, JT
Washington, JA
机构
[1] CLEVELAND CLIN FDN,DEPT CLIN PATHOL,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT ANAT PATHOL,CLEVELAND,OH 44195
关键词
D O I
10.1128/JCM.34.3.508-511.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess the impact of the antiseptic effects of silver sulfadiazine-chlorhexidine-impregneted central venous catheters on catheter culture systems, a series of in vitro experiments was performed. Segments of antiseptic- and non-antiseptic-impregnated catheters were sonicated in thioglycolate broth and removed. After the addition of 10(3) CFU of Staphylococcus epidermidis per ml, aliquots of catheter-exposed broth were subcultured onto blood agar at 15-min intervals. Decreased mean colony counts were noted at 45 min for broth exposed to antiseptic-impregnated catheters compared with the colony counts for broth exposed to non-antiseptic-impregnated catheters (170 versus 540 CFU/ml). These effects, which were also demonstrated by the roll-plate method, were abrogated by the use of medium containing inhibitors of silver sulfadiazine and chlorhexidine. To assess the duration of the antiseptic effects, catheter segments were suspended for up to 14 days in phosphate-buffered saline, incubated with 10(6) CFU of S. epidermidis per ml, and cultured. Inhibition of bacterial growth by antiseptic-impregnated catheters disappeared after 14 days. These studies suggest that antiseptic compounds elute from catheters during broth- and solid medium-based culturing processes, making necessary the addition of inhibitors of these compounds in culture media. They further suggest that the antimicrobial effects of antiseptic-impregnated catheters wane within several days of placement.
引用
收藏
页码:508 / 511
页数:4
相关论文
共 11 条
[1]  
CLEMENCE MA, 1994, 34 INT C ANT AG CHEM, P194
[2]   A CONTROLLED TRIAL OF SCHEDULED REPLACEMENT OF CENTRAL VENOUS AND PULMONARY-ARTERY CATHETERS [J].
COBB, DK ;
HIGH, KP ;
SAWYER, RG ;
SABLE, CA ;
ADAMS, RB ;
LINDLEY, DA ;
PRUETT, TL ;
SCHWENZER, KJ ;
FARR, BM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) :1062-1068
[3]   NOSOCOMIAL INFECTION-RATES IN ADULT AND PEDIATRIC INTENSIVE-CARE UNITS IN THE UNITED-STATES [J].
JARVIS, WR ;
EDWARDS, JR ;
CULVER, DH ;
HUGHES, JM ;
HORAN, T ;
EMORI, TG ;
BANERJEE, S ;
TOLSON, J ;
HENDERSON, T ;
GAYNES, RP ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S185-S191
[4]   PROSPECTIVE-STUDY OF REPLACING ADMINISTRATION SETS FOR INTRAVENOUS THERAPY AT 48-HOUR VS 72-HOUR INTERVALS - 72 HOURS IS SAFE AND COST-EFFECTIVE [J].
MAKI, DG ;
BOTTICELLI, JT ;
LEROY, ML ;
THIELKE, TS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (13) :1777-1781
[5]   PROSPECTIVE RANDOMIZED TRIAL OF POVIDONE-IODINE, ALCOHOL, AND CHLORHEXIDINE FOR PREVENTION OF INFECTION ASSOCIATED WITH CENTRAL VENOUS AND ARTERIAL CATHETERS [J].
MAKI, DG ;
RINGER, M ;
ALVARADO, CJ .
LANCET, 1991, 338 (8763) :339-343
[6]   SEMIQUANTITATIVE CULTURE METHOD FOR IDENTIFYING INTRAVENOUS-CATHETER-RELATED INFECTION [J].
MAKI, DG ;
WEISE, CE ;
SARAFIN, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (23) :1305-1309
[7]  
MAKI DG, 1991, 31ST INT C ANT AG CH, P176
[8]  
MODAK SM, 1992, COMPLICATION SURG, V1792, P23
[9]  
National Committee for Clinical Laboratory Standards, 1993, M2A5 NCCLS
[10]  
RAAD II, 1994, INFECT CONT HOSP EP, V15, P231